Trials / Completed
CompletedNCT04760951
Effect of Totum-070 on Lipid Metabolism in Moderate Hypercholesterolemic Subjects
Randomized Placebo-controlled Double-blinded Study of the Effect of TOTUM-070 on Lipid Metabolism in Moderate Hypercholesterolemic Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Valbiotis · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This clinical study aims to assess the efficacy of TOTUM-070, a mix of 5 plant extracts, on lipid metabolism in moderate hypercholesterolemic subjects. The hypothesis is that TOTUM-070, daily consumed, is superior to placebo for decrease of fasting blood LDL-cholesterol concentration (determined by ultracentrifugation method) after 24 weeks of consumption.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | TOTUM-070 | 5-g dose of TOTUM-070 diet supplement, a mix of 5 plant extracts. Eight capsules per day to consume orally in two intakes |
| DIETARY_SUPPLEMENT | Placebo | Placebo. Eight capsules per day to consume orally in two intakes |
Timeline
- Start date
- 2021-02-17
- Primary completion
- 2022-02-17
- Completion
- 2022-02-17
- First posted
- 2021-02-18
- Last updated
- 2022-03-29
Locations
4 sites across 2 countries: France, Germany
Source: ClinicalTrials.gov record NCT04760951. Inclusion in this directory is not an endorsement.